These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7225227)

  • 1. [Effect of aging on stability and dissolution velocity of controlled-release ferrous sulfate tablets].
    Raggi MA; Cavrini V; Di Pietra AM
    Boll Chim Farm; 1980 Nov; 119(11):663-8. PubMed ID: 7225227
    [No Abstract]   [Full Text] [Related]  

  • 2. A profile scanning method of studying the release properties of different types of tablets in man.
    Alpsten M; Ekenved G; Sölvell L
    Acta Pharm Suec; 1976; 13(2):107-22. PubMed ID: 937006
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and optimization of the drug release determination of iron from iron prolonged release tablets.
    Kincl M; Bibic R; Veber M; Vrecer F
    Pharmazie; 2003 Apr; 58(4):257-9. PubMed ID: 12749408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of iron supplementation: a comparative trial of a wax-matrix iron preparation and conventional ferrous sulfate tablets.
    Brock C; Curry H; Hanna C; Knipfer M; Taylor L
    Clin Ther; 1985; 7(5):568-73. PubMed ID: 4053146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of severe hookworm anaemia by a sustained slow-release ferrous sulphate preparation, Plexafer.
    Kiire CF; Nantulya VM; Otim MA
    East Afr Med J; 1980 Mar; 57(3):218-22. PubMed ID: 7389609
    [No Abstract]   [Full Text] [Related]  

  • 6. Biopharmaceutical evaluation of ferrous salts in form of oral long-acting tablets.
    Krzyśko K; Bokowski W; Wichliński LM
    Pol J Pharmacol Pharm; 1984; 36(1):73-7. PubMed ID: 6462964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis.
    Hershko C; Ianculovich M; Souroujon M
    Acta Haematol; 2007; 118(1):19-26. PubMed ID: 17426393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron resorption after gastrectomy and Tardyferon treatment.
    Heinrich HC; Gabbe EE
    Med Klin; 1979 Aug; 74(34):1225-7. PubMed ID: 502955
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of an effect of oral iron administration on mycophenolic acid pharmacokinetics in stable renal transplant recipients.
    Gelone DK; Park JM; Lake KD
    Pharmacotherapy; 2007 Sep; 27(9):1272-8. PubMed ID: 17723081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does your patient need more iron?
    Cerrato PL
    RN; 1990 Jul; 53(7):63-6. PubMed ID: 2371509
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of spherical iron(II) sulfate heptahydrate-containing solid particles with sustained drug release.
    Szabó-Révész P; Farkas B; Gregor T; Nagy K; Pallagi E
    Eur J Pharm Biopharm; 2007 May; 66(2):193-9. PubMed ID: 17125982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor clinical response to enteric-coated iron preparations.
    Rudinskas L; Paton TW; Walker SE; Dotten DA; Cowan DH
    CMAJ; 1989 Sep; 141(6):565-6. PubMed ID: 2776097
    [No Abstract]   [Full Text] [Related]  

  • 13. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin.
    Chowdary KP; Kamalakara RG
    Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral iron therapy: preparations with rapid or delayed iron liberation?].
    Kaltwasser JP; Ockelmann R; Schalk KP
    Med Klin (Munich); 1987 Oct; 82(21):730-5. PubMed ID: 3683337
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of an effect of ferrous sulfate on phenytoin absorption in the rat.
    Campbell NR; Hasinoff BB; Robertson S; Singh M
    Clin Invest Med; 1993 Aug; 16(4):280-4. PubMed ID: 8306537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some dissolution aspects of ferrous sulfate tablets.
    Blezek CE; Lach JL; Guillory JK
    Am J Hosp Pharm; 1970 Jul; 27(7):533-9. PubMed ID: 5431051
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro evaluation of iron solubility and dialyzability of various iron fortificants and of iron-fortified milk products targeted for infants and toddlers.
    Kapsokefalou M; Alexandropoulou I; Komaitis M; Politis I
    Int J Food Sci Nutr; 2005 Jun; 56(4):293-302. PubMed ID: 16096139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Automated sampling and analysis procedure for dissolution tests of Fe2+ drug preparations].
    Herzfeldt CD; Erben A
    Pharmazie; 1984 Nov; 39(11):783-4. PubMed ID: 6531388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.